Migraine in women

Affiliations

¹ Department of Neurology, Stanford University School of Medicine, Stanford Health Care, Stanford, California, USA.
² Department of Neurology, University of Vermont Medical Center, Faulkner Hospital, Boston, Massachusetts, USA.
³ Department of Neurology, Mayo Clinic, Scottsdale, Arizona, USA.

Editorial

Arathi Nandyala et al. Headache. 2024 Sep.

. 2024 Sep;64(8):909-911.

doi: 10.1111/head.14783. Epub 2024 Jun 14.

¹ Department of Neurology, Stanford University School of Medicine, Stanford Health Care, Stanford, California, USA.
² Department of Neurology, University of Vermont Medical Center, Faulkner Hospital, Boston, Massachusetts, USA.
³ Department of Neurology, Mayo Clinic, Scottsdale, Arizona, USA.

No abstract available

References

1. Verhagen IE, van der Arend BWH, van Casteren DS, le Cessie S, MaassenVanDenBrink A, Terwindt GM. Sex differences in migraine attack characteristics: a longitudinal E‐diary study. Headache. 2023;63(3):333‐341.
1. Shapiro HFJ, Loder E, Shapiro DJ. Association between clinician specialty and prescription of preventive medication for young adults with migraine: a retrospective cohort study. Headache. 2023;63(9):1232‐1239.
1. Hranilovich JA, Millington K. Headache prevalence in transgender and gender diverse youth: a single‐center case–control study. Headache. 2023;63(4):517‐522.
1. Graf M, Kim E, Brewer I, et al. Expert consensus established around flexible, individualized migraine treatment utilizing a modified Delphi panel. Headache. 2023;63(4):506‐516.
1. MacGregor EA, Hutchinson S, Lai H, et al. Safety and efficacy of ubrogepant for the acute treatment of perimenstrual migraine attacks: a post hoc analysis. Headache. 2023;63(8):1135‐1144.